2-Aryl Benzimidazole Derivatives Act as Potent Urease Inhibitors; Synthesis, Bioactivity and Molecular Docking Study

References

• B. Kahveci, E. Menteşe, M, Özil, S. Ülker, and M. Ertürk, “An Efficient Synthesis of Benzimidazoles via a Microwave Technique and Evaluation of Their Biological Activities,” Monatshefte Für Chemie - Chemical Monthly 144, no. 7 (2013): 993–1001.
   Google Scholar
• E. Menteşe, S. Ülker, and B. Kahveci, “Synthesis and Study of α-Glucosidase Inhibitory, Antimicrobial and Antioxidant Activities of Some Benzimidazole Derivatives Containing Triazole, Thiadiazole, Oxadiazole, and Morpholine Rings,”Chemistry of Heterocyclic Compounds 50, no. 12 (2015): 1671–82.
   Web of Science ®Google Scholar
• F. Yılmaz, E. Menteşe, and N. Baltaş, “Synthesis and Antioxidant Evaluation of Some Novel Benzimidazole Derivatives Containing a Triazole Nucleus,”Letters in Drug Design & Discovery 14, no. 2 (2016): 201–8.
   Web of Science ®Google Scholar
• T. M. A. Eldebss, A. M. Farag, M. M. Abdulla, and R. K. Arafa, “Novel Benzo [d] Imidazole-Based Heterocycles as Broad Spectrum anti-Viral Agents: design, Synthesis and Exploration of Molecular Basis of Action,” Mini Reviews in Medicinal Chemistry 16, no. 1 (2016): 67–83.
   PubMed Web of Science ®Google Scholar
• L. Stuchlíková, R. Jirásko, L. Skálová, F. Pavlík, B. Szotáková, M. Holčapek, T. Vaněk, and R. Podlipná, “Metabolic Pathways of Benzimidazole Anthelmintics in Harebell (Campanula Rotundifolia),” Chemosphere 157 (2016): 10–7.
   PubMed Web of Science ®Google Scholar
• E. Menteşe, F. Yılmaz, M. Emirik, S. Ülker, and B. Kahveci, “Synthesis, Molecular Docking and Biological Evaluation of Some Benzimidazole Derivatives as Potent Pancreatic Lipase Inhibitors,” Bioorganic Chemistry 76 (2018): 478–86.
   PubMed Web of Science ®Google Scholar
• J. Velık, V. Baliharova, J. Fink-Gremmels, S. Bull, J. Lamka, and L. Skálová, “Benzimidazole Drugs and Modulation of Biotransformation Enzymes,” Research in Veterinary Science 76, no. 2 (2004): 95–108.
   PubMed Web of Science ®Google Scholar
• M. Gaba, and C. Mohan, “Development of Drugs Based on Imidazole and Benzimidazole Bioactive Heterocycles: Recent Advances and Future Directions,” Medicinal Chemistry Research 25, no. 2 (2016): 173–210.
   Web of Science ®Google Scholar
• H. A. Barker, R. D. Smyth, H. Weissbach, J. I. Toohey, J. N. Ladd, and B. E. Volcani, “Isolation and Properties of Crystalline Cobamide Coenzymes Containing Benzimidazole or 5, 6-Dimethylbenzimidazole,” The Journal of Biological Chemistry 235, no. 2 (1960): 480–8.
   PubMed Web of Science ®Google Scholar
• B. V. S. Kumar, S. D. Vaidya, R. V. Kumar, S. Bhaskar Bhirud, and R. B. Mane, “Synthesis and anti-Bacterial Activity of Some Novel 2-(6-Fluorochroman-2-yl)-1-Alkyl/Acyl/Aroyl-1H-Benzimidazoles,” European Journal of Medicinal Chemistry 41, no. 5 (2006): 599–604.
   PubMed Web of Science ®Google Scholar
• E. Menteşe, H. Bektaş, B. B. Sokmen, M. Emirik, D. Çakır, and B. Kahveci, “Synthesis and Molecular Docking Study of Some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole Derivatives Bearing Triazole, Oxadiazole, and Imine Functionalities as Potent Inhibitors of Urease ,” Bioorganic & Medicinal Chemistry Letters 27, no. 13 (2017): 3014–8.
   PubMed Web of Science ®Google Scholar
• T. Arshad, K. M. Khan, N. Rasool, U. Salar, S. Hussain, H. Asghar, M. Ashraf, A. Wadood, M. Riaz, S. Perveen, et al. “5-Bromo-2-Aryl Benzimidazole Derivatives as Non-Cytotoxic Potential Dual Inhibitors of α-Glucosidase and Urease Enzymes,” Bioorganic Chemistry 72 (2017): 21–31.
   PubMed Web of Science ®Google Scholar
• H. Aman, N. Rashid, Z. Ashraf, A. Bibi, H.-T. Chen, and N. Sathishkumar, “Synthesis, Density Functional Theory (DFT) Studies and Urease Inhibition Activity of Chiral Benzimidazoles,” Heliyon 6, no. 10 (2020): e05187.
   PubMed Web of Science ®Google Scholar
• K. Zaman, F. Rahim, M. Taha, H. Ullah, A. Wadood, M. Nawaz, F. Khan, Z. Wahab, S. A. A. Shah, A. Ur Rehman, et al. “Synthesis, in Vitro Urease Inhibitory Potential and Molecular Docking Study of Benzimidazole analogues,” Bioorganic Chemistry 89 (2019): 103024.
   PubMed Web of Science ®Google Scholar
• E. Menteşe, M. Emirik, and B. Bilgin Sökmen, “Design, Molecular Docking and Synthesis of Novel 5,6-dichloro-2-methyl-1H-benzimidazole Derivatives as Potential Urease Enzyme Inhibitors ,” Bioorganic Chemistry 86 (2019): 151–8.
   PubMed Web of Science ®Google Scholar
• F. Begum, N. B. Almandil, M. A. Lodhi, K. M. Khan, A. Hameed, and S. Perveen, “Synthesis and Urease Inhibitory Potential of Benzophenone Sulfonamide Hybrid in Vitro and in Silico,” Bioorganic & Medicinal Chemistry 27, no. 6 (2019): 1009–22.
   PubMed Web of Science ®Google Scholar
• M. Kazmi, I. Khan, A. Khan, S. A. Halim, A. Saeed, S. Mehsud, A. Al-Harrasi, and A. Ibrar, “Developing New Hybrid Scaffold for Urease Inhibition Based on Carbazole-Chalcone Conjugates: Synthesis, Assessment of Therapeutic Potential and Computational Docking Analysis,” Bioorganic & Medicinal Chemistry 27, no. 22 (2019): 115123.
   PubMed Web of Science ®Google Scholar
• H. G. Abdulwahab, M. F. Harras, N. G. El Menofy, A. M. Hegab, B. M. Essa, A. A. A. Selim, T. M. Sakr, and H. S. A. El-Zahabi, “Novel Thiobarbiturates as Potent Urease Inhibitors with Potential Antibacterial Activity: Design, Synthesis, Radiolabeling and Biodistribution study,” Bioorganic & Medicinal Chemistry 28, no. 23 (2020): 115759.
   PubMed Web of Science ®Google Scholar
• H. Meier, M. M. El- Abadelah, M. Z. Nazer, and N. S. El-Abadla, “Dioxides. PART I. 2-(N-2-Hydroxyalkylcarba-Moyl) Derivatives,”Heterocycles 41, no. 10 (1995): 2203.
   Google Scholar
• R. J. Abdel-Jalil, and W. Voelter, “Synthesis of New 2‐Ferrocenyl‐5‐Fluoro‐6‐(4‐Substituted‐1‐Piperazinyl)‐1H‐Benzimidazoles of Potential Biological Interest,” Journal of Heterocyclic Chemistry 42, no. 1 (2005): 67–71.
   Web of Science ®Google Scholar
• M. Talebi, E. Hamidian, F. Niasari-Naslaji, S. Rahmani, F. S. Hosseini, S. Boumi, M. N. Montazer, M. Asadi, and M. Amanlou, “Synthesis, Molecular Docking, and Biological Evaluation of Nitroimidazole Derivatives as Potent Urease Inhibitors,” Medicinal Chemistry Research 30, no. 6 (2021): 1220–9.
   Web of Science ®Google Scholar
• F. Saravani, E. S. Moghadam, H. Salehabadi, S. Ostad, M. P. Hamedani, M. Amanlou, M. A. Faramarzi, and M. Amini, “Synthesis, anti-Proliferative Evaluation, and Molecular Docking Studies of 3-(Alkylthio)-5, 6-Diaryl-1, 2, 4-Triazines as Tubulin Polymerization Inhibitors,” Letters in Drug Design & Discovery 16, no. 11 (2019): 1194–201.
   Web of Science ®Google Scholar
• Ebrahim Saeedian Moghadam, Farhad Saravani, Seyednasser Ostad, Shohreh Tavajohi, Morteza Pirali Hamedani, and Mohsen Amini, “Design, Synthesis and Cytotoxicity Evaluation of Indibulin Analogs,” Heterocyclic Communications 24, no. 4 (2018): 211–7.
   Web of Science ®Google Scholar